153 related articles for article (PubMed ID: 23660368)
1. Taxanes: old drugs, new oral formulations.
Jibodh RA; Lagas JS; Nuijen B; Beijnen JH; Schellens JH
Eur J Pharmacol; 2013 Oct; 717(1-3):40-6. PubMed ID: 23660368
[TBL] [Abstract][Full Text] [Related]
2. Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel.
Koolen SL; Beijnen JH; Schellens JH
Clin Pharmacol Ther; 2010 Jan; 87(1):126-9. PubMed ID: 19924122
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
4. Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation.
Hendrikx JJ; Lagas JS; Wagenaar E; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Br J Cancer; 2014 May; 110(11):2669-76. PubMed ID: 24781280
[TBL] [Abstract][Full Text] [Related]
5. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.
van Waterschoot RA; Lagas JS; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Song JY; Rooswinkel RW; van Tellingen O; Rosing H; Beijnen JH; Schinkel AH
Cancer Res; 2009 Dec; 69(23):8996-9002. PubMed ID: 19920203
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of taxanes.
Malingré MM; Beijnen JH; Schellens JH
Invest New Drugs; 2001 May; 19(2):155-62. PubMed ID: 11392449
[TBL] [Abstract][Full Text] [Related]
7. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
[TBL] [Abstract][Full Text] [Related]
8. Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel--a review.
de Weger VA; Beijnen JH; Schellens JH
Anticancer Drugs; 2014 May; 25(5):488-94. PubMed ID: 24637579
[TBL] [Abstract][Full Text] [Related]
9. Modulation of oral bioavailability of anticancer drugs: from mouse to man.
Schellens JH; Malingré MM; Kruijtzer CM; Bardelmeijer HA; van Tellingen O; Schinkel AH; Beijnen JH
Eur J Pharm Sci; 2000 Dec; 12(2):103-10. PubMed ID: 11102737
[TBL] [Abstract][Full Text] [Related]
10. Advances in the formulations of non-injection administration of docetaxel.
Zhang H; Dou J; Zhai Y; Liu A; Zhai G
J Drug Target; 2014 Feb; 22(2):87-94. PubMed ID: 24098909
[TBL] [Abstract][Full Text] [Related]
11. The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
Press RR; Buckle T; Beijnen JH; van Tellingen O
Cancer Chemother Pharmacol; 2006 Jun; 57(6):819-25. PubMed ID: 16163538
[TBL] [Abstract][Full Text] [Related]
12. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
Bardelmeijer HA; Ouwehand M; Buckle T; Huisman MT; Schellens JH; Beijnen JH; van Tellingen O
Cancer Res; 2002 Nov; 62(21):6158-64. PubMed ID: 12414642
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
Lee JH; Lee A; Oh JH; Lee YJ
Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
[TBL] [Abstract][Full Text] [Related]
15. From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies.
Koolen SL; van Waterschoot RA; van Tellingen O; Schinkel AH; Beijnen JH; Schellens JH; Huitema AD
J Clin Pharmacol; 2012 Mar; 52(3):370-80. PubMed ID: 21505085
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice.
Tang SC; Kort A; Cheung KL; Rosing H; Fukami T; Durmus S; Wagenaar E; Hendrikx JJ; Nakajima M; van Vlijmen BJ; Beijnen JH; Schinkel AH
Mol Pharm; 2015 Oct; 12(10):3714-23. PubMed ID: 26317243
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin.
Yan YD; Kim DH; Sung JH; Yong CS; Choi HG
Int J Pharm; 2010 Oct; 399(1-2):116-20. PubMed ID: 20727390
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.
Malingré MM; Richel DJ; Beijnen JH; Rosing H; Koopman FJ; Ten Bokkel Huinink WW; Schot ME; Schellens JH
J Clin Oncol; 2001 Feb; 19(4):1160-6. PubMed ID: 11181682
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.
Koolen SL; Oostendorp RL; Beijnen JH; Schellens JH; Huitema AD
Br J Clin Pharmacol; 2010 May; 69(5):465-74. PubMed ID: 20573082
[TBL] [Abstract][Full Text] [Related]
20. Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.
Otová B; Václavíková R; Danielová V; Holubová J; Ehrlichová M; Horský S; Soucek P; Simek P; Gut I
Eur J Pharm Sci; 2006 Dec; 29(5):442-50. PubMed ID: 17000091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
